Osteomyelitis Caused by Kluyvera Ascorbata, a Rare Pathogen: First Case Report in Colombia
DOI:
https://doi.org/10.58814/01208845.653Keywords:
Osteomyelitis, Tibia, Fractures, Bone, Drug Resistance, KluyveraAbstract
Introduction: Osteomyelitis is a common bone infection, most frequently associated with Staphylococcus aureus and, less commonly, with Gram-negative bacilli, particularly in patients with trauma or previous surgical interventions. In this context, Kluyvera ascorbata, an environmental enterobacterium and commensal organism of the human gastrointestinal tract, has rarely been implicated in clinical infections. Its involvement in osteoarticular infections is exceptionally rare, and according to the literature review, no cases of long-bone osteomyelitis caused by this microorganism have been reported to date.
Case Presentation: A 52-year-old previously healthy man sustained an open proximal tibial fracture and a closed distal tibial fracture following a traffic accident. He underwent surgical management at another institution but subsequently developed a fracture-related infection, requiring multiple debridement procedures and ultimately resulting in knee ankylosis. Six months later, he was referred to the institution with a chronic draining sinus and exposed bone. Radical debridement was performed, and intraoperative tissue cultures yielded Staphylococcus capitis, Serratia marcescens, and Kluyvera ascorbata. Targeted antimicrobial therapy was initiated based on culture results. Two additional surgical procedures were required to achieve infection control and provide soft-tissue coverage using a local flap. The patient experienced a favorable clinical outcome, with complete sinus tract closure, satisfactory soft-tissue coverage, and no evidence of infection recurrence after six months of follow-up.
Conclusion: This report describes the first documented case of chronic tibial osteomyelitis associated with K. ascorbata. This case highlights the importance of intraoperative cultures and the need to consider emerging pathogens in complex osteoarticular infections. Osteomyelitis caused by K. ascorbata is exceptionally rare. Accurate microbiological diagnosis is essential to guide appropriate treatment in complex fracture-related infections.
Downloads
References
1. Masters EA, Ricciardi BF, Bentley KL de M, Moriarty TF, Schwarz EM, Muthukrishnan G. Skeletal infections: microbial pathogenesis, immunity and clinical management. Nat Rev Microbiol. 2022;20(7):385-400. https://doi.org/10.1038/s41579-022-00686-0 PMID: 35169289; PMCID: PMC8852989.
2. Kremers HM, Nwojo ME, Ransom JE, Wood-Wentz CM, Melton LJ, Huddleston PM. Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009. J Bone Joint Surg Am. 2015;97(10):837-45. https://doi.org/20.2106/JBJS.N.01350 PMID: 25995495; PMCID: PMC4642868.
3. Bury DC, Rogers TS, Dickman MM. Osteomyelitis: Diagnosis and Treatment. Am Fam Physician. 2021;104(4):395-402. PMID: 34652112.
4. Hoyos-Orrego Á, Mantilla-Mantilla LF. Microbiology of bone-joint infections in children at a university clinic in Medellín, Colombia. Infect. 2023;27(1):29-35. https://doi.org/10.22354/24223794.1116
5. Lee J, Hwang JH, Jo DS, Lee HS, Hwang JH. Kluyvera ascorbata as a Pathogen in Adults and Children: Clinical Features and Antibiotic Susceptibilities in a Single Center Study. Jpn J Infect Dis. 2019;72(3):142-8. https://doi.org/10.7883/yoken.JJID.2028.375 PMID: 30504643.
6. Karadag Oncel E, Ozsurekci Y, Akyon Y, Gur D, Cengiz AB, Kara A. Kluyvera ascorbata infections in children: a case series. Turk Pediatri Ars. 2015;50(2):123-8. https://doi.org/10.5152/tpa.2015.923 PMID: 26265898; PMCID: PMC4523986.
7. O’Connor O, Thahir A, Krkovic M. How Much Does an Infected Fracture Cost? Arch Bone Jt Surg. 2022;10(2):135-40. https://doi.org/10.22038/abjs.2021.53590.2665 PMID: 35655742. PMCID: PMC9117895.
8. Zou SH, Zhu LY, Li Y, Zhang FG. A Case of a Persistent Postoperative Infection Caused by Multidrug-Resistant Kluyvera ascorbata in the Oral and Maxillofacial Region. Case Rep Infect Dis. 2019;2180567:1-4. https://doi.org/101155/2019/2180567 PMID: 30838146; PMCID: PMC6374812.
9. Mutoh Y, Kobe T, Hirano T, Ichihara T, Takenaka H, Niinomi T, et al. The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature. IDCases. 2019;15:e00498. https://doi.org/10.1016/j.idcr.2019.e00498 PMID: 30775241; PMCID: PMC6365812.
10. Wajima T, Hirai Y, Otake T, Momose Y, Nakaminami H, Noguchi N. First isolation of an IMP-1 metallo-β-lactamase-producing Kluyvera ascorbata in Japan. J Glob Antimicrob Resist. 2020;23:228-31. https://doi.org/10.1016/j.jgar.2020.09.026 PMID: 33065331.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 The Author(s).

This work is licensed under a Creative Commons Attribution 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |










